JOSHUA PILKENTON: Open Payments
NPI 1972043602 · ENGLEWOOD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$533 in 30 payments from 12 companies in 2025. Trend: 2023 $158 · 2024 $457 · 2025 $533
Food & beverage: $533
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $142 |
| AstraZeneca Pharmaceuticals LP | 5 | $85 |
| Abbott Laboratories | 3 | $55 |
| Lilly USA, LLC | 3 | $52 |
| Amgen Inc. | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Xeris Pharmaceuticals, Inc. | 2 | $33 |
| Dexcom, Inc. | 1 | $31 |
| Tandem Diabetes Care, Inc. | 1 | $22 |
| ABBVIE INC. | 1 | $19 |
Products named: Wegovy, JARDIANCE, FARXIGA, FREESTYLE LIBRE 3, Rybelsus, Dexcom G6 Transmitter, Ozempic, t:slim X2 Insulin Pump with Control-IQ.
Industry payments across OH — which companies pay providers there.
